Ultrahuman, a global leader in wearable health technology, has partnered with Clue, the #1 women-led period and cycle tracker, to provide women with a more seamless and affordable way to understand their bodies.
As part of the partnership, every purchase of the Ultrahuman Ring AIR now includes a full year of Clue Plus for $9.99 – reduced from $39.99.
Clue Plus unlocks personalized cycle tracking, deeper analysis, advanced predictions, hormone insights, and features designed for pregnancy, perimenopause, and more. It also provides extended 12-month forecasting and expert-backed guidance from clinicians to help users better understand their bodies.
Learn more: How to connect Ultrahuman and Clue
Smarter insights with no extra effort
Ultrahuman users can connect their Clue account and automatically import up to six months of cycle history and view it alongside Ring AIR’s real-time biomarker data – including heart rate variability, resting heart rate, and skin temperature.
This combined view provides women with a broader picture of their health, bringing together cycle patterns and daily biomarkers in one place. By removing the need for double logging, it becomes easier to notice connections, reflect on health goals, and adapt routines in ways that feel aligned with their bodies.
A partnership built for women
“This collaboration is about providing women with choice and confidence in their health journey,” said Kate Davies, VP Medical, Women’s Health & Longevity at Ultrahuman. “By combining the biomarker insights of the Ring AIR with Clue Plus, we are enabling seamless, cycle-aware health tracking that helps women reflect on their bodies with greater ease.”
Rhiannon White, CEO at Clue added: “At Clue, we want to see a world where women live better. Partnering with Ultrahuman allows us to further deepen the rich dataset women build in the Clue app, empowering them to take control of their own health and live the lives they envisage for themselves. We are excited to bring this partnership to women and people with cycles across the world, making it easier for them to have full health agency.”
Investment in women’s health
Ultrahuman’s recent acquisition of viO HealthTech, the creators of the clinically validated OvuSense™ fertility algorithm, further reinforces its commitment to accuracy in women’s health.
With its Clue integration and Clue Plus available for just $9.99 per year, Ultrahuman gives women greater choice in how they track their cycle. Whether the goal is fertility awareness or a deeper understanding of personal patterns, women can select the experience that fits them best.
This partnership marks the beginning of a new chapter in how women engage with their health: with greater clarity, convenience, and confidence.
